These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Synthesis of novel halogenated triarylpyrazoles as selective COX-2 inhibitors: Anti-inflammatory activity, histopatholgical profile and in-silico studies. Abdellatif KRA; Abdelall EKA; Labib MB; Fadaly WAA; Zidan TH Bioorg Chem; 2020 Dec; 105():104418. PubMed ID: 33166844 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, characterization and in vitro and in vivo anti-inflammatory evaluation of novel pyrazole-based chalcones. Chavan HV; Adsul LK; Kotmale AS; Dhakane VD; Thakare VN; Bandgar BP J Enzyme Inhib Med Chem; 2015 Feb; 30(1):22-31. PubMed ID: 24666306 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study. El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309 [TBL] [Abstract][Full Text] [Related]
11. Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors. Murahari M; Mahajan V; Neeladri S; Kumar MS; Mayur YC Bioorg Chem; 2019 May; 86():583-597. PubMed ID: 30782576 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors. Cheng H; Lundy DeMello KM; Li J; Sakya SM; Ando K; Kawamura K; Kato T; Rafka RJ; Jaynes BH; Ziegler CB; Stevens R; Lund LA; Mann DW; Kilroy C; Haven ML; Nimz EL; Dutra JK; Li C; Minich ML; Kolosko NL; Petras C; Silvia AM; Seibel SB Bioorg Med Chem Lett; 2006 Apr; 16(8):2076-80. PubMed ID: 16464588 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Tewari AK; Singh VP; Yadav P; Gupta G; Singh A; Goel RK; Shinde P; Mohan CG Bioorg Chem; 2014 Oct; 56():8-15. PubMed ID: 24893208 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors. Abdellatif KR; Abdelgawad MA; Labib MB; Zidan TH Bioorg Med Chem Lett; 2015 Dec; 25(24):5787-91. PubMed ID: 26546221 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel 2-mercaptobenzoxazole based 1,2,3-triazoles as inhibitors of proinflammatory cytokines and suppressors of COX-2 gene expression. Haider S; Alam MS; Hamid H; Shafi S; Dhulap A; Hussain F; Alam P; Umar S; Pasha MA; Bano S; Nazreen S; Ali Y; Kharbanda C Eur J Med Chem; 2014 Jun; 81():204-17. PubMed ID: 24836072 [TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel 2-phenyl-5-(1,3-diphenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazoles as selective COX-2 inhibitors with potent anti-inflammatory activity. Bansal S; Bala M; Suthar SK; Choudhary S; Bhattacharya S; Bhardwaj V; Singla S; Joseph A Eur J Med Chem; 2014 Jun; 80():167-74. PubMed ID: 24780593 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, Anti-Inflammatory Activity, and COX-1/2 Inhibition Profile of Some Novel Non-Acidic Polysubstituted Pyrazoles and Pyrano[2,3-c]pyrazoles. Faidallah HM; Rostom SAF Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28370254 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel 1,2,3-triazole based benzoxazolinones: their TNF-α based molecular docking with in-vivo anti-inflammatory, antinociceptive activities and ulcerogenic risk evaluation. Haider S; Alam MS; Hamid H; Shafi S; Nargotra A; Mahajan P; Nazreen S; Kalle AM; Kharbanda C; Ali Y; Alam A; Panda AK Eur J Med Chem; 2013; 70():579-88. PubMed ID: 24211633 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of 1,5-diaryl-1,2,4-triazole derivatives as selective cyclooxygenase-2 inhibitors. Jiang B; Zeng Y; Li MJ; Xu JY; Zhang YN; Wang QJ; Sun NY; Lu T; Wu XM Arch Pharm (Weinheim); 2010 Sep; 343(9):500-8. PubMed ID: 20842641 [TBL] [Abstract][Full Text] [Related]
20. New methyl 5-(halomethyl)-1-aryl-1H-1,2,4-triazole-3-carboxylates as selective COX-2 inhibitors and anti-inflammatory agents: Design, synthesis, biological evaluation, and docking study. Li SM; Tsai SE; Chiang CY; Chung CY; Chuang TJ; Tseng CC; Jiang WP; Huang GJ; Lin CY; Yang YC; Fuh MT; Wong FF Bioorg Chem; 2020 Nov; 104():104333. PubMed ID: 33142408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]